Renal dialysis market seen reaching $41.38B by 2035

Market Research Future projects the global renal dialysis market will grow from $24.0 billion in 2025 to $41.38 billion by 2035, driven by rising chronic kidney disease, reimbursement changes and home-dialysis incentives. North America leads now, while Asia-Pacific is expected to grow fastest through 2035.

Why it matters: - The renal dialysis market is expanding as kidney disease rates rise and providers shift more care into home settings. - The forecast points to more demand for dialysis equipment, remote monitoring and home-based treatment systems over the next decade. - Policy changes in the U.S. are improving the economics of dialysis investments and accelerating technology upgrades.

What happened: - Market Research Future projected the global renal dialysis market will rise from $24.0 billion in 2025 to $41.38 billion by 2035. - The report put the market at $20.05 billion in 2021. - The forecast implies a 5.6% compound annual growth rate from 2026 through 2035. - The report tied growth to chronic kidney disease prevalence, ESRD reimbursement reform and home-therapy incentives. - Market Research Future provided a free sample and detailed insights.

The details: - The World Health Organization estimates chronic kidney disease affects about 850 million adults worldwide. - The U.S. Centers for Medicare & Medicaid Services raised the End-Stage Renal Disease bundled payment base rate by 2.1% for calendar year 2025 to about $271.02 per treatment. - CMS' ESRD Treatment Choices model links payment adjustments to home dialysis use and is pushing purchases of peritoneal dialysis cyclers and home hemodialysis systems. - Roughly 2.6 million patients worldwide currently receive some form of renal replacement therapy. - Lancet estimates that number could exceed 5 million by 2030. - Fresenius Medical Care said its AI-based predictive analytics platform cut unplanned machine downtime by 35% across 250 pilot clinics in North America during 2024. - Baxter International is investing more than $300 million in next-generation automated peritoneal dialysis cycler systems. - DaVita continues expanding integrated care and home dialysis programs.

Between the lines: - The market is being shaped by a shift from in-center dialysis toward home treatment, not just by raw patient growth. - Reimbursement now matters as much as clinical need because payment rules can reward or penalize providers based on home-dialysis adoption. - AI, connected devices and predictive maintenance are becoming competitive advantages for manufacturers and large dialysis networks. - The report also suggests the market may split over time between conventional equipment and newer wearable or portable therapy models.

What's next: - Home-based dialysis is likely to keep gaining share as CMS-linked incentives remain in place and remote monitoring improves. - Portable and wearable kidney-therapy devices are emerging as a possible next wave, with prototypes targeting regulatory submission before 2028. - Government-funded dialysis programs in India, China, Indonesia and Egypt are expected to add capacity in faster-growing markets. - By 2035, the report expects wearable therapy to shift 10% to 15% of patient volume away from fixed installations.

The bottom line: - Dialysis demand is growing, but the bigger story is how care is moving toward home, digital monitoring and newer treatment platforms.